(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
This phase II trial is studying how well GDC-0449 works in treating adult patients with recurrent or refractory medulloblastoma.
For more information contact: Cincinnati Children’s Hospital Medical Center Division of Hematology/Oncology 3333 Burnet Ave., Cincinnati, OH 45229-3039 Phone: 513-636-2799 email@example.com
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center